<SEC-DOCUMENT>0001206774-14-002352.txt : 20140805
<SEC-HEADER>0001206774-14-002352.hdr.sgml : 20140805
<ACCEPTANCE-DATETIME>20140805080026
ACCESSION NUMBER:		0001206774-14-002352
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20140731
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20140805
DATE AS OF CHANGE:		20140805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		141014641

	BUSINESS ADDRESS:	
		STREET 1:		149 COMMONWEALTH DRIVE
		STREET 2:		SUITE 2070
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		149 COMMONWEALTH DRIVE
		STREET 2:		SUITE 2070
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>geron_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR><BR>
<P align=center><B><FONT face="Times New Roman" size=2>UNITED STATES
<BR></FONT></B><B><FONT face="Times New Roman" size=2>SECURITIES AND EXCHANGE
COMMISSION <BR>WASHINGTON, D.C. 20549 <BR>___________<BR></FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>FORM 8-K</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CURRENT
REPORT<BR></FONT></B><B><FONT face="Times New Roman" size=2>PURSUANT TO SECTION
13 OR 15(d) OF THE <BR>SECURITIES EXCHANGE ACT OF 1934</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>Date of Report (Date of
Earliest Event Reported):</FONT> <B><FONT face="Times New Roman" size=2>July 31,
2014</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>GERON
CORPORATION</FONT></B> <FONT face="Times New Roman" size=2><BR></FONT><FONT face="Times New Roman" size=2>(Exact name of registrant as specified in its
charter)</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><B><FONT face="Times New Roman" size=2>Delaware</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><B><FONT face="Times New Roman" size=2>0-20859</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><B><FONT face="Times New Roman" size=2>75-2287752</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><FONT face="Times New Roman" size=2>(State or other jurisdiction</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><FONT face="Times New Roman" size=2>(Commission File Number)</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><FONT face="Times New Roman" size=2>(IRS Employer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><FONT face="Times New Roman" size=2>of incorporation)</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="33%"><FONT face="Times New Roman" size=2>Identification
No.)</FONT></TD></TR></TABLE><BR>
<P align=center><B><FONT face="Times New Roman" size=2>149 COMMONWEALTH DRIVE,
SUITE 2070 <BR>MENLO PARK, CALIFORNIA 94025 <BR></FONT></B><FONT face="Times New Roman" size=2>(Address of principal executive offices, including
zip code)</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>(650)
473-7700<BR></FONT></B><FONT face="Times New Roman" size=2>(Registrant&#146;s
telephone number, including area code)</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>N/A <BR></FONT></B><FONT face="Times New Roman" size=2>(Former name or former address, if changed since
last report)</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:</FONT></P>
<P align=left>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"><FONT face=wingdings size=2>o</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="98%">
      <P><FONT face="Times New Roman" size=2>Written communications pursuant to
      Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P></TD></TR>
  <TR>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="98%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD></TR>
  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"><FONT face=Wingdings size=2>o</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="98%">
      <P><FONT face="Times New Roman" size=2>Soliciting material pursuant to
      Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P></TD></TR>
  <TR>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="98%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD></TR>
  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"><FONT face=Wingdings size=2>o</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="98%">
      <P><FONT face="Times New Roman" size=2>Pre-commencement communications
      pursuant to Rule 14d-2(b) under the Exchange Act (17 </FONT><FONT face="Times New Roman" size=2>CFR 240.14d-2(b))</FONT></P></TD></TR>
  <TR>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD width="98%"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD></TR>
  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"><FONT face=Wingdings size=2>o</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="1%"></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="98%">
      <P><FONT face="Times New Roman" size=2>Pre-commencement communications
      pursuant to Rule 13e-4(c) under the Exchange Act (17 </FONT><FONT face="Times New Roman" size=2>CFR
240.13e-4(c))</FONT></P></TD></TR></TABLE></P>
<HR align=center width="100%" noShade SIZE=2>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Item 1.01 Entry into a
Material Definitive Agreement. </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Times New Roman" size=2>On July 31, 2014, Geron Corporation (&#147;Geron&#148; or the &#147;Company&#148;) and Mayo
Clinic entered into a transfer agreement (the &#147;Transfer Agreement&#148;) whereby the
Investigational New Drug application (&#147;IND&#148;) for imetelstat under which the
investigator-sponsored trial to assess the effect of imetelstat in patients with
myelofibrosis (the &#147;Myelofibrosis IST&#148;) has been conducted will be transferred
to Geron. In addition, the parties have agreed that Geron will assume
responsibility for the conduct of the Myelofibrosis IST as the trial sponsor. In
connection with entering into the Transfer Agreement, Mayo Clinic has
transferred data from the clinical database (the &#147;Transferred Information&#148;) for
the Myelofibrosis IST to Geron. Subject to completion of the obligations and
receipt of the deliverables described in the transfer plan that is part of the
Transfer Agreement, Geron and Mayo Clinic agreed that the IND and responsibility
for the Myelofibrosis IST as the trial sponsor will be transferred to Geron by
September 30, 2014. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT size=3 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company does not intend to
enroll additional patients in the Myelofibrosis IST and plans to continue to
conduct the Myelofibrosis IST at Mayo Clinic until the trial is closed. Dr.
Ayalew Tefferi will continue as the principal investigator for the trial.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT size=3 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Transfer Agreement also includes
certain indemnifications, including, upon completion of the activities set forth
in the transfer plan and subject to certain customary exceptions, a release of
liability from any and all claims by the Company arising from the Transferred
Information and the IND.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT size=3 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The foregoing description of the
Transfer Agreement is a summary of the material terms of the Transfer Agreement,
which will be filed as an exhibit to Geron&#146;s quarterly report on Form 10-Q for
the quarter ended September 30, 2014. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 8.01 Other
Events.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2><FONT size=3 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Craig C. Parker has resigned from
his position as the Company&#146;s Executive Vice President, Corporate Development
and Scientific Affairs to pursue other opportunities, effective July 31, 2014.
Melissa A. Behrs, currently Executive Vice President, Portfolio and Alliance
Management, will oversee business development activities under the new title
Executive Vice President, Business Development and Portfolio &amp; Alliance
Management. In addition, Andrew J. Grethlein, Ph.D., currently Executive Vice
President, Technical Operations, has been appointed Executive Vice President,
Development and Technical Operations, to reflect his additional responsibilities
for development activities for the Company. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>SIGNATURE </FONT></B></P>
<P align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Times New Roman" size=2>Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="10%" colSpan=2><FONT face="Times New Roman" size=2>GERON CORPORATION</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Date: August 5, 2014</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">By:&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="9%"><FONT face="Times New Roman" size=2>/s/ Stephen N.
  Rosenfield</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="9%"><FONT face="Times New Roman" size=2>Stephen N. Rosenfield</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="9%"><FONT face="Times New Roman" size=2>Executive Vice President, General</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="9%"><FONT face="Times New Roman" size=2>Counsel and Corporate
Secretary</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>3 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
